Table of Contents
BIRMINGHAM, Ala. — Under a partnership, Centrix Pharmaceutical Inc. plans to promote CutisPharma Inc.’s FIRST Progesterone VGS vaginal suppository compounding kits.
Centrix said Thursday that starting in early July, its sales representatives will promote CutisPharma’s FIRST Progesterone VGS compounding kits nationwide in retail pharmacies as well as in doctor’s offices, clinics and hospitals that specialize in obstetrics and gynecology.
The product line includes FIRST Progesterone VGS 25, 50, 100, 200 and 400. The kits are made for one patient and include preweighed progesterone and a suppository base, along with a unique, patented disposable suppository mold for the preparation, dispensing and storage of the suppositories — all in one unit designed to boost patient compliance and provide greater ease of use.
According to the companies, the use of FIRST VGS kits enables pharmacists to compound a prescription for 30 vaginal suppositories four to five times faster than those prepared in the conventional way using a metal suppository mold or polystyrene shells, which reduces patient wait times and raises customer satisfaction. In addition, a single NDC number assigned for the entire kit facilitates the third-party reimbursement process and reduces audit-related adjustments.
